Case studies
Discover our latest case studies, featuring concrete examples of collaborations with biotech and pharma teams developing cell-based therapies. Each case study offers a clear, transparent view of how our expertise in process and analytical development, cell banking, GMP manufacturing, and regulatory support helps accelerate cell therapy programs while reducing development risks.
Quality by Design Reveals What Standard Process Development Misses
This case study shows how a Quality by Design (QbD) approach combined with Design of Experiments (DoE) can uncover critical interactions between process parameters that are missed by traditional one-factor-at-a-time development.
Solving the Scale-Up Barrier: How We Engineered a High-Yield, In Vivo-Ready T-Cell Process
Scaling up a T-cell therapy from lab-scale to large-scale manufacturing can be challenging. Our goal was to transform a small-scale proof-of-concept into a robust, scalable, process suitable for in vivo studies.
From R&D to GMP: Successful Clinical-Grade Manufacturing of an NK Cell Therapy
Our client, a European biotech working on an allogeneic NK cell immunotherapy, had initially developed their process in an academic research setting suitable for small-scale R&D and exploratory work.
An off-the-shelf MSC product derived from lab-scale autologous process
Drawing on our expertise in the field of autologous MSCs, our local researchers, professors and clinicians wanted to offer patients suffering from various autoimmune diseases an affordable and safe treatment.